Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN15351014
ISRCTN15351014
Completed
未知

Evaluation of endothelial dysfunction in prediabetes and diabetes mellitus in patients with normal coronary arteries using flow-mediated dilation of brachial artery

Ankara Guven Hospital0 sites73 target enrollmentSeptember 23, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEndothelial dysfunction in patients with diabetes and pre-diabetes with normal coronary arteriesCirculatory System

Overview

Phase
未知
Intervention
Not specified
Conditions
Endothelial dysfunction in patients with diabetes and pre-diabetes with normal coronary arteries
Sponsor
Ankara Guven Hospital
Enrollment
73
Primary Endpoint
Flow-mediated dilation is measured by an ultrasound system equipped with a 5-10 MHz linear array transducer from the brachial artery at baseline and after vasodilation, using an ultrasound, taken once per patient
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 23, 2024
End Date
December 30, 2010
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ankara Guven Hospital

Eligibility Criteria

Inclusion Criteria

  • •Patients evaluated in the Cardiology outpatient clinic who were found to have normal coronary arteries on coronary angiography
  • •Aged 21-80 years

Exclusion Criteria

  • •A history of previous percutaneous coronary intervention
  • •Atrial fibrillation
  • •Heart failure
  • •More than mild valvular regurgitation
  • •Valvular stenosis
  • •Uncontrolled hypertension (systolic blood pressure = 160 mmHg and diastolic blood pressure =90 mmHg in the last 6 weeks)
  • •Cardiomyopathy
  • •Chronic kidney or liver disease

Outcomes

Primary Outcomes

Flow-mediated dilation is measured by an ultrasound system equipped with a 5-10 MHz linear array transducer from the brachial artery at baseline and after vasodilation, using an ultrasound, taken once per patient

Secondary Outcomes

  • There are no secondary outcome measures

Similar Trials

Completed
Not Applicable
Assessment of vascular form and function in Diabetes Mellitus by Non Invasive Vascular toolsdiabetesdiabetes mellitus100110821001265310003216
NL-OMON32397eids Universitair Medisch Centrum500
Not yet recruiting
Not Applicable
Assessment of endothelial dysfunction and premature atherosclerosis in patients with recent onset Rheumatoid Arthritis, a longitudinal studygewrichtsaandoeningenrheumatoid arthritis10003216
NL-OMON33873niversitair Medisch Centrum Groningen60
Active, not recruiting
Not Applicable
Assessment of endothelial function in patients with psoriasis before and after Etanercept treatment - NDmoderate to severe psoriasisMedDRA version: 6.1Level: PTClassification code 10037153
EUCTR2006-007011-24-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI40
Not yet recruiting
Not Applicable
Analysis of endothelial function of patients with large vessel vasculitis and ANCA-associated small vessel vasculitisM31.6M31.5M31.3M31.7M30.1Giant cell arteritis with polymyalgia rheumaticaOther giant cell arteritisWegener granulomatosisMicroscopic polyangiitisPolyarteritis with lung involvement [Churg-Strauss]
DRKS00005139niversitätsklinikum Jena100
Completed
Not Applicable
Evaluation of effect of chromium compounds on endothelial dysfunction and lipid profile in type 2 diabeticsHealth Condition 1: null- Type 2 diabetes mellitus
CTRI/2017/08/009489Dr C Uday Kumar96